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The gene is composed of 16 verified exons spanning 
23.6 kb. 
Transcription 
Encodes a single confirmed 2788 nt transcript 
(NM_006342) (Still et al., 1999), although one 
additional transcript with two additional small 5' coding  
exons between exon 1 and the first coding exon (exon 
2), based on NM_006342, is indicated based on several 
cDNAs that may however be from suspect cDNA 
libraries (see UCSC Genome Bioinformatics Site 
(http://genome.ucsc.edu)). Four additional transcripts 
variants are suggested based on singleton Expressed 
sequence tags in tumor cell lines (AW516785, 

















TACC3 encodes a single protein of 838 amino acids 
with a molecular mass of 90 kDa (Still et al., 1999). 
The protein is heavily phosphorylated based on direct 
evidence and based on predictions from the Xenopus 
and mouse orthologs (Beausoleil et al., 2004; 
Beausoleil et al., 2008; Kinoshita et al., 2005; Yu et al., 
2007; Cantin et al., 2008; Dephoure et al., 2008). Thus, 
human TACC3 migrates at approxi-mately 150 kDa in  
SDS-PAGE. Additional variants are suggested based 
on singleton cDNAs (see above) but their predicted 
protein isoforms have not been confirmed. 
Expression 
High levels during early (mouse) embryogenesis, in 
particular during early differentiation of specific t ssues 
(Sadek et al., 2003). In adult tissues, expression is 
relatively limited, with high levels noted in 
hematological tissues such as the thymus, spleen and 
leukocytes, and reproductive tissues, especially meiotic 
cells of the testes and ovary (Still et al., 1999; Sadek et 
al., 2003).  
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Epithelial layers of the lung, mammary gland and ovary 
express TACC3 and alterations in expression are notd 
during tumorigenesis (see below). Expression in human 
adult tissues is summarized in Lauffart et al. 2006. 
Localisation 
Human (and mouse) TACC3 is located in the 
interphase nucleus and/or cytosol, depending on cell 
type and cancer type (Gergely et al., 2000; Aitola et l., 
2003; Lauffart et al., 2005; Jung et al., 2006; 
Vettaikkorumakankauv et al., 2008). TACC3 does not 
however contain a classical nuclear localisation signal 
(Still et al., 1999). TACC3 associates with the 
centrosome in a cell cycle dependent manner (Gergely 
et al., 2000). Phosphorylation of TACC3 by Aurora A 
on key serine residues is required for this interaction 
(Kinoshita et al., 2005; LeRoy et al., 2007). 
Overexpression of TACC3 from artificial constructs 
can result in accumulation in the cytosol of some cells 
resulting in oligmerisation in punctate structures 
(Gergely et al., 2000). 
Function 
Gene knockout and knockdown studies in mouse have 
indicated that TACC3 is vital for embryonic 
development. A functionally null TACC3 mutant dies 
during mid to late gestation due to excessive apoptosis 
affecting hematopoietic and other organ systems 
(Piekorz et al., 2002). Hypomorphic alleles result in 
defects in mitosis affecting mesenchymal sclerotome 
and therefore the axial skeleton (Yao et al., 2007). 
These mutational mouse models indicate that TACC3 
has a role in chromosomal alignment, separation and 
cytokinesis and that TACC3 can be associated with 
p53-mediated apoptosis. 
TACC3 has a well characterized function in 
microtubule dynamics, particularly during mitosis, 
based on mutational analysis (see above) and physical 
interactions with Aurora A and Aurora B kinases, 
CKAP5 (ch-TOG/XMAP215) and AKAP9 via the 
TACC domain (see Peset and Vernos, 2008 for 
review). Interaction with CEP120 is important in 
interkinetic nuclear migration and maintenance of 
neural progenitor self-renewal during the development 
of the neocortex (Xie et al., 2007). Phosphorylation of 
Ser34, Ser552 and Ser558 by Aurora A are required for 
localization to centro-somes and is necessary for 
recruitment of CKAP5 and nucleation of microtubules 
(Kinoshita et al., 2005; LeRoy et al., 2007). Ser25, 
Thr59, Ser71, Ser317, and Ser 434 are presumed  
targets for cyclin dependent kinases in mitotic HeLa 
cells (Yu et al., 2007; Cantin et al., 2008; Dephoure et 
al., 2008). By homology, Ser558 phosphorylation by 
TPX2 is required for nucleation of microtubules in 
meiotic oocytes (Brunet et al., 2008). 
TACC3 also has a defined role in interphase cells as a 
transcriptional cofactor for the aryl-nuclear translocator 
protein (Sadek, 2000), FOG1 (Garriga-Canut and 
Orkin, 2004; Simpson et al., 2004) and is a possible 
indirect activator of CREB via FHL family of 
coactivator/corepressor proteins (Lauffart et al., 
2007b). Roles in transcriptional regulation  
 
have also been proposed based on TACC3 binding to 
GAS41 (YEATS4) via the SDP repeat, histone acetyl 
transferases hGCN5L2 (KAT2A), pCAF (KAT2B), 
and retinoid X-receptor beta via the TACC domain 
(Gangisetty, 2004; Lauffart et al., 2002; 
Vettaikkorumakankauv et al., 2008). TACC3 
functionally interacts with MBD2 bound to methylated 
promoters, promoting transcription by displacement of 
HDAC2 and recruitment of KAT2B (Angrisano et al., 
2006). Human TACC3 may be involved in 
transcriptional termination and/or pre-mRNA splicing 
through TTF2 (Leonard et al., 2003). TACC3 can 
interact with BARD1, BRCA1 and p53 and has been 
shown to have some protective affects against 
adriamycin-mediated DNA damage in ovarian cancer 
cells (Lauffart et al., 2007a). Phosphorylation of the 
last amino acid of the SDP repeat, Ser434, is noted in 
nuclear extracts of HeLa (Beausoleil, 2004; Beausoleil, 
2006), although its functional significance is unknow . 
Homology 
Member of the TACC family, based on the presence of 
the evolutionarily conserved approxi- 
mately 200 amino acid carboxy terminal coiled coil 
domain (TACC domain) (Still et al., 1999; Still et al., 
2004). TACC3 orthologues are noted in all vertebrates 
sequenced to date (Still et al., 2004 and Still 
unpublished). However, the central region between th  
conserved N-terminal region and the TACC domain is 
highly variable in size and sequence. The SDP repeats 
are noted within the central region in most vertebrates 
except mouse and rat (Still et al., 2004). 
Mutations 
Note 
Somatic mutations noted in ovarian cancer samples 
(Lauffart et al., 2005; Eslinger, 2006). 
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Overexpression of TACC3 is associated with 
chemoresistance in ovarian tumors (L'Esperance et al., 
2006). 
Oncogenesis 
Total cellular expression or nuclear localization lst in 
ovarian cancer (Lauffart et al., 2005). 
Non-small cell lung cancer 
Prognosis 
High TACC3 expression is an independent prognostic 
indicator associated with significantly shorter median 
survival time. TACC3 expression was correlated with 
p53 expression and poor prognosis (Jung et al., 2006). 
Oncogenesis 
A high level of TACC3 expression was observed in 
14.8% of cases of non small cell lung cancer, 
predominantly of the squamous cell carcinoma type 
(Jung et al., 2006). 
Breast cancer 
Prognosis 
Loss of TACC3 is observed as a predictor of poor 
prognosis in breast cancer (Conte et al., 2002). 
Oncogenesis 
TACC3 protein downregulated in breast cancer (Conte 
et al., 2002). 
Multiple myeloma 
Prognosis 
TACC3 overexpression correlates with the t(4;14) 
translocation that is associated with poor prognosis 
(Stewart et al., 2004). 
Oncogenesis 
TACC3 is located close to the MMSET gene that is 
rearranged in t(4;14) translocation (Still et al., 1999). 
This rearrangement upregulates the TACC3 gene 
(Stewart et al., 2004). 
Thyroid cancer 
Prognosis 
Reduction of expression associated with increased 
malignancy in cell line models (Ulisse et al., 2007). 
Oncogenesis 
Analysis of differentiated thyroid cancers indicates hat 
TACC3 mRNA levels were either upregulated (44%) 
or downregulated (56%) in tumors, in some cases 
correlation was observed between TACC3 and Aurora-
A kinase (Ulisse et al., 2007). However protein analysis 
was not reported. 
Breakpoints 
Note 
Rearrangements of the human TACC3 gene have not 
been described. However, translocation breakpoints in 
the WHSC1 gene, associated with multiple myeloma 
upregulate the intact TACC3 promoter (Stewart et al., 
2004). Tacc3 in the mouse genome is a site of proviral 
integration of MoMuLV transmitted via milk from 
infected mothers. This leads to upregulation of the gene 
and leads to the development of lymphomas 
(Chakraborty et al., 2008). 
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